The Path of Most Resistance: Transdifferentiation Underlies Exceptional Nonresponses to Androgen Receptor Pathway Inhibition in Prostate Cancer. [electronic resource]
Producer: 20180329Description: 673-674 p. digitalISSN:- 2159-8290
No physical items for this record
Publication Type: Journal Article; Comment
There are no comments on this title.
Log in to your account to post a comment.